article thumbnail

Target-directed cancer: protein-ligand interactions  

Drug Target Review

The team that I lead within the CCDD is called the Hit Discovery and Structural Design Team. We support the drug discovery projects of the CCDD with assay development and screening, biophysics, structural biology and recombinant protein production. Capivasertib (orange) bound to the kinase domain of AKT (blue).